The Valley Desk

NCT02599324 · Interventional trial

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

Overall registry status Completed

Phase 1 · Phase 2

Conditions Advanced Gastric Adenocarcinoma, Advanced Urothelial Carcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Renal Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov